Keratoconus is a progressive corneal disorder that affects patients’ vision. It is a relatively common condition in which there is an abnormality in the shape of the cornea. The normal cornea consists of a round, dome-like shape that is regular and symmetric throughout. In patients with keratoconus, the cornea takes on an irregular shape that causes part of the dome to become thin and develop a cone-like bulge. This results in distortion of the cornea that blurs vision and can make certain daily activities difficult due to poor vision.
Although the disease is present in both eyes, symptoms are often asymmetric between the two eyes. The disease, and thus symptoms, usually start to occur in patients in their late teens and twenties. Complaints typically consist of blurring of vision, distortion of vision, or sensitivity to light and glare. As the disease progresses, patients may notice worsening vision, rapid changes in their prescriptions, or an inability to wear contact lenses.
During the early stages of the disease, a patient’s vision can often be corrected with eyeglasses. However, as the disease progresses, contact lenses and specifically rigid gas permeable lenses may be required to correct the distorted vision.
The latest treatment for keratoconus is a procedure called corneal collagen crosslinking. Although not currently FDA-approved, the procedure has been performed for years overseas. Results from numerous studies have been very promising as a means for preventing further progression of the disease. It is anticipated that this procedure will be approved for use in the USA in 2012.
In circumstances when good vision is no longer possible with contact lenses, or a patient cannot tolerate contact lenses, a corneal transplant may be recommended. A corneal transplant is necessary in about 15-20% of patients with keratoconus. Of all conditions requiring corneal transplants, keratoconus has the best prognosis for clear vision.
Patients should refrain from rubbing their eyes as this can potentially make symptoms worse. Patients who have keratoconus are not candidates for LASIK, or laser vision correction, as this can exacerbate the condition and make vision worse.
Most of our physicians have sub-specialty fellowship training in pediatric ophthalmology, glaucoma, retinal disease and surgery, oculoplastics and cosmetics, and corneal and refractive surgery.Leading Multi-Specialty Eye Care
With the latest advances, having clear vision at only one distance is no longer the only option.Premium Lens Implant Technology
Lexington Eye Associates has the most advanced diagnostic tools available to help to determine whether or not a patient has glaucoma, to assess the type of glaucoma that is present, and also to monitor the disease over time.Cutting-Edge Glaucoma Treatment
We offer patients in Massachusetts the most advanced diagnostic equipment. Our fellowship trained retina specialists are skilled in the state-of-the-art treatments that are preventing vision loss.Advances in Macular Degeneration
Advanced technology now allow for minimally invasive surgery by targeting disease and performing partial thickness transplantation, such as DSAEK surgery.The Latest in Corneal Transplants
Our pediatric ophthalmologists are the most highly skilled specialists in Massachusetts for treatment of Lazy Eye, Amblyopia and other related eye disorders.Current Therapy for Lazy Eye